Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.6B | 4.8B | 4.5B | 4.3B |
Cost of revenue | 3.1B | 3.2B | 3.0B | 2.9B |
Gross profit | 1.6B | 1.5B | 1.5B | 1.4B |
Operating expense | ||||
Research & development | 26.4M | 32.3M | 29.9M | 30.7M |
Selling general and admin | 703.3M | 699.5M | 698.1M | 686.8M |
Other operating expenses | — | — | — | — |
Operating income | 831.6M | 816.2M | 726.3M | 695.7M |
Non operating interest income | ||||
Income | 4.4M | 12.6M | 3.3M | 11.7M |
Expense | 36.5M | 31.0M | 37.3M | 31.1M |
Other income expense | — | — | — | — |
Pretax income | 885.7M | 905.1M | 890.7M | 942.9M |
Tax provision | 165.3M | 182.9M | 155.6M | 137.6M |
Net income | 720.5M | 722.2M | 735.1M | 805.4M |
Basic EPS | 1.6 | — | 1.6 | 1.8 |
Diluted EPS | 1.6 | — | 1.6 | 1.8 |
Basic average shares | 443.8M | — | 442.9M | 443.2M |
Diluted average shares | 444.2M | — | 445.6M | 443.2M |
EBITDA | 1.4B | 1.4B | 1.4B | 1.4B |
Net income from continuing op. | 885.7M | 905.1M | 890.7M | 942.9M |
Minority interests | -14.8M | -11.7M | -8.8M | -16.4M |
Preferred stock dividends | 0 | 0 | 0 | 0 |